Clinical Trial Update: A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications [Phase 1]

View source ↗

Summary

Phase 1 safety, tolerability, and pharmacokinetics study of AMG 794 in Claudin-6–positive cancers, including non-small cell lung cancer and ovarian cancer, has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Ovarian Cancer

Drugs mentioned

• AMG 794

Snippet

Sponsor: Amgen | Conditions: Non-squamous Non-small Cell Lung Cancer, Epithelial Ovarian Cancer | Phase 1 | Status: TERMINATED